SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Association of antipsychotic use with raised eosinophil count.

Tsamakis, K; Mueller, C; Hortis, I; Kallergi, M; Tolos, I; Alevyzakis, E; Siafakas, N; Ouranidis, A; Tsiptsios, D; Kympouropoulos, S; et al. Tsamakis, K; Mueller, C; Hortis, I; Kallergi, M; Tolos, I; Alevyzakis, E; Siafakas, N; Ouranidis, A; Tsiptsios, D; Kympouropoulos, S; Spandidos, DA; Smyrnis, N; Rizos, E (2021) Association of antipsychotic use with raised eosinophil count. Exp Ther Med, 21 (5). p. 513. ISSN 1792-0981 https://doi.org/10.3892/etm.2021.9944
SGUL Authors: Tsamakis, Konstantinos

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (509kB) | Preview

Abstract

The current study aimed to assess the possibility of an association between first and second generation antipsychotic medication and raised eosinophil count. A total of 22 in-patients at the psychiatric unit of the University General Hospital 'Attikon', a tertiary hospital, were included in the present study. Patients had received antipsychotic monotherapy and did not have any co-morbidities or require additional treatments. Patients were monitored weekly and their eosinophil count was assessed. One-way ANOVA and summary measures analysis were applied to study the effect of time and medication type on the absolute eosinophil concentration (or relative percentage) for each patient. The differences in mean eosinophil concentrations or relative percentage by patient and time were also assessed. An increase in the absolute concentration and the relative percentage of eosinophils over time was observed in patients receiving Olanzapine, Haloperidol and Aripiprazole. However, there was no difference between individual medications. In conclusion, antipsychotics may be associated with increased eosinophil count over time; however, larger studies involving more patients and a longer follow-up are required to reach a definitive conclusion.

Item Type: Article
Additional Information: © Tsamakis et al. This is an open access article distributed under the terms of Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc-nd/4.0/). This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License.
Keywords: antipsychotics, aripiprazole, eosinophil count, first and second generation, haloperidol, monotherapy, olanzapine, antipsychotics, eosinophil count, monotherapy, first and second generation, olanzapine, haloperidol, aripiprazole
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Journal or Publication Title: Exp Ther Med
ISSN: 1792-0981
Language: eng
Dates:
DateEvent
May 2021Published
19 March 2021Published Online
26 January 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 33791022
Web of Science ID: WOS:000635072500001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113395
Publisher's version: https://doi.org/10.3892/etm.2021.9944

Actions (login required)

Edit Item Edit Item